glp 1 gip microdose Microdosing for Weight Loss Tirzepatide Microdose Program | Fierce

Acknowledgements This work was supported by the National Institutes of Health (R01 GM056414, to S.H.G.)

You might be a candidate if: You have a BMI of 30 or higher (classified as obesity) You have a BMI of 27 or higher with at least one weight-related condition such as: High blood pressure High cholesterol Sleep apnea Fatty liver disease Polycystic ovary syndrome (PCOS) Joint problems related to excess weight Clinical trials have shown that Mounjaro can help people lose an average of 15-20% of their body weight over about a year, which is significantly more than most other anti-obesity medications

After that, skip it and wait for your next scheduled dose

Some people might feel hungrier while using creatine and eat more, which could lead to fat gain if not managed with a balanced diet